Roop Kalyan Lakkaraju Benchmark Electronics Inc (BHE) insider trading activity

Roop Kalyan Lakkaraju is EVP, Chief Financial Officer of BENCHMARK ELECTRONICS INC. Currently has a direct ownership of 150,716 shares of BHE, which is worth approximately $5.94 Million. The most recent transaction as insider was on Feb 26, 2024, when has been sold 2,801 shares (Common Stock) at a price of $29.97 per share, resulting in proceeds of $83,945. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K

0% 3M change

20.36% 12M change

Total Value Held $5.94 Million

Roop Kalyan Lakkaraju Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2024	SELL Payment of exercise price or tax liability	$83,945 $29.97 p/Share	2,801 Reduced 1.82%	150,716 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$95,700 $29.73 p/Share	3,219 Reduced 2.05%	153,517 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	25,321 Added 13.91%	156,736 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$389,151 $29.22 p/Share	13,318 Reduced 9.2%	131,415 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	19,516 Added 11.88%	144,733 Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$66,495 $23.74 p/Share	2,801 Reduced 2.19%	125,217 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	27,653 Added 17.76%	128,018 Common Stock

Feb 22 2023	SELL Payment of exercise price or tax liability	$323,761 $24.25 p/Share	13,351 Reduced 11.74%	100,365 Common Stock
Feb 22 2023	BUY Exercise of conversion of derivative security	-	28,556 Added 20.07%	113,716 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$192,933 $24.25 p/Share	7,956 Reduced 8.54%	85,160 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	24,067 Added 20.54%	93,107 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$147,405 $25.56 p/Share	5,767 Reduced 7.71%	69,040 Common Stock
Jan 10 2022	SELL Payment of exercise price or tax liability	$42,485 $26.67 p/Share	1,593 Reduced 2.09%	74,807 Common Stock
Aug 04 2021	BUY Open market or private purchase	$2,595 $25.95 p/Share	100 Added 0.13%	76,400 Common Stock
Aug 03 2021	BUY Open market or private purchase	$47,466 $26.37 p/Share	1,800 Added 2.3%	76,300 Common Stock
Mar 05 2021	BUY Open market or private purchase	$26,788 $29.6 p/Share	905 Added 1.2%	74,500 Common Stock
Mar 02 2021	BUY Open market or private purchase	$49,795 $29.64 p/Share	1,680 Added 2.23%	73,595 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$120,869 $28.48 p/Share	4,244 Reduced 5.57%	71,915 Common Stock
Feb 19 2021	BUY Grant, award, or other acquisition	-	17,483 Added 18.67%	76,159 Common Stock
Jan 08 2021	SELL Payment of exercise price or tax liability	$37,413 $28.98 p/Share	1,291 Reduced 2.15%	58,676 Common Stock

Also insider at

INFN

Infinera Corp Technology

Director

BIO

BIO-RAD LABORATORIES, INC. Healthcare

EVP, Chief Financial Officer

RKL